Apixaban has received a positive opinion from the CHMP, for the prevention of VTE in adult patients who have undergone elective hip or knee replacement surgery. Approval is almost certain. http://www.reuters.com/article/2011/03/18/bms-pfizer-apixiban-idUSLDE72H18920110318